Exhibit 10.4
 
Confidential Materials omitted and filed separately with the
Securities and Exchange Commission. Double asterisks denote omissions.
 
[exhibit10-4.gif]
 

 

--------------------------------------------------------------------------------

 
SECTION B – SUPPLIES OR SERVICES AND PRICES/COSTS
ITEM
SUPPLIES/SERVICES
QTY/UNIT
UNIT
PRICE
EXTENDED PRICE
0002-02
BioThrax [**] product
BioThrax [**] product
[**] upon date of delivery [**]
 
Corresponds to Line Item 0002B in contract.
 
To be delivered in accordance with the delivery schedule below
[**] Doses
$[**]
$[**]
 
Line(s) Of Accounting: 939ZTGA 2642 2012 75-X-0956 5664711101 $[**]
 
 
 

Option 1 Option for Additional Items:
ITEM
SUPPLIES/SERVICES
QTY/UNIT
UNIT
PRICE
EXTENDED PRICE
0002-02
BioThrax [**] product
BioThrax [**] product
[**] upon date of delivery [**]
 
To be delivered in accordance with the delivery schedule below
[**] Doses
$[**]
$[**]
 
Line(s) Of Accounting: 939ZTGA 2642 2012 75-X-0956 5664711101 [**]
 
 
 

The purpose of this modification is to transfer funds between CLINS, modify the
product doses as described and incorporate these in scope changes to contract
#200-2011-42084.
A.
The contract funded amount for CLIN 0002 is decreased by $[**] from $[**] to
$[**]. CLIN0002 is reduced in quantity from [**] product doses to [**] product
doses.

As a result:
1.
CLIN 0002- 02 is is funded in the amount of $[**] for [**] product doses.

2.
Section C.2 Delivery Schedule and section F.3.1 are revised as follows:

--------------------------------------------------------------------------------

 

Product
 
CLIN
Price per
Dose
Doses
$
Delivery Period
0001
[**]
[**]
[**]
October 1, 2011 to December 31, 2012
0002
[**]
[**]
[**]
January 1, 2013 to November 30, 2013
0002-02
[**]
[**]
[**]
January 1, 2013 to November 30, 2014
0003
[**]
[**]
[**]
December 1, 2013 to November 30, 2014
0004
[**]
[**]
[**]
December 1, 2014 to October 31, 2015
0005
[**]
[**]
[**]
November 1, 2015 to September 30, 2016
Total
 
44,750,000
$1,234,775,641.30
 

Consider all other terms and conditions of the contract unchanged and in full
force and effect.